Orchard Therapeutics plc Annual Income Tax Expense (Benefit) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Orchard Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2022.
  • Orchard Therapeutics plc Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $976K.
  • Orchard Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2023 was -$140K, a 87.5% increase year-over-year.
  • Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was -$2.37M, a 387% decline from 2021.
  • Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $828K.
  • Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2020 was -$731K, a 67.4% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$2.37M -$3.2M -387% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $828K +$1.56M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$731K +$1.51M +67.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$2.24M -$3.21M -331% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $970K +$917K +1730% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $53K +$33K +165% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $20K Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.